CHJ.70109
apo-Transferrin human
--
--
Ordering
Available Variants100 mg
CHJ.70109-100mg
Price
€232.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHJ.70109-100mg | €232.80 |
≥95% protein basis (biuret)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| CAS Number | 11096-37-0 |
|---|---|
| UNSPSC Code | 12352202 |
| EC Number | 234-318-8 |
| NACRES | NA.61 |
| MDL number | MFCD00130536 |
| eCl@ss | 34058011 |
| Form | powder |
| Assay | ≥95% protein basis (biuret), ≥98% (agarose gel electrophoresis) |
| Biological source | human |
| Mol wt | 76-81 kDa |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
Technical Overview & Applications Use-case context
Apo-Transferrin human, also known as apotransferrin, is a glycoprotein with a molecular weight of approximately 80 kDa, and its CAS number is 11096-37-0. It is an iron-free form of transferrin, a protein responsible for the transport of iron in the blood. Apo-Transferrin human is composed of a single polypeptide chain and has a high affinity for iron, allowing it to bind and transport this essential metal ion. The protein plays a crucial role in maintaining iron homeostasis in the body, and its deficiency has been linked to various diseases, including anemia and neurodegenerative disorders. Apo-Transferrin human is often used as a research tool in studies related to iron metabolism and as a component in cell culture media to support cell growth and differentiation. Its applications also extend to the diagnosis and treatment of iron-related disorders.
